start portlet menu bar

Visualitzador de contingut web

Display portlet menu
end portlet menu bar

Serological response to Erysipelothrix Rhusiopathiae in gilts receiving various commercialised vaccines

Inici Coneixement Serological response to Erysipelothrix Rhusiopathiae in gilts receiving various commercialised vaccines

Serological response to Erysipelothrix Rhusiopathiae in gilts receiving various commercialised vaccines

The aim of this study was to compare the humoral immune response provided by four commercialised reproductive vaccines against swine erysipelas (SE) and porcine parvovirus (PPV), under field conditions in Denmark. 

Sobre aquest article

Publicat en

European Symposium of Porcine Health Management, 2018

Data

10 jul. 2018

Autors

Pedersen, K.S.; Camprodon, A.; Llopart, D.; Jorda, R.; Strunz, A.M.

Resum

Gilts vaccinated with ERYSENG® PARVO exhibited the highest serological response compared with animals vaccinated with one of the other three commercialised vaccines against E. rhusiopathiae.

Productes relacionats

Compartir

The contents of this page are country specific and aimed specifically at prescribing veterinarians.

This product is not available in {{ preferredCountry.title }}.

You will be redirected to our global site. Click on continue to visit our global site (available in English).

Confirm that you are a veterinary professional:

This product is not available in {{ countrySelect.title }}.

You will be redirected to our global site. Click on continue to visit our global site (available in English).

  • I am a veterinarian (otherwise please contact a veterinary professional)

Select your country:

Country {{countrySelect.title}}
  • Global (available in English)
  • {{country.title}}